Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-22

FDA Approved: TERIFLUNOMIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for teriflunomide from Mylan Pharmaceuticals Inc., authorizing a generic product. Teriflunomide is used to treat relapsi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)